7 research outputs found
Effect of the irrigation method and genotype on the bioaccumulation of toxic and trace elements in rice
The total concentration of three toxic elements (As, Cd and Pb) and five oligoelements (Cu, Mn, Mo, Ni and Se) has been determined using an original and completely validated ICP-MS method. This was applied to rice grains from 26 different genotypes cultivated in the same soil and irrigated with the same water in three different ways: by the traditional continuous flooding (CF) and by two intermittent methods, the sprinkler irrigation (SP) and the periodical saturation of the soil (SA). The adoption of SP hugely minimizes the average amounts of almost all elements in kernels (−98% for As, −90% for Se and Mn, −60% for Mo, −50% for Cd and Pb), with the only exception of Ni, whose concentration increases the average amount found in the CF rice by 7.5 times. Also SA irrigation is able to reduce the amounts of As, Mo and Pb in kernels but it significantly increases the amounts of Mn, Ni and – mainly - Cd. Also the nature of the genotype determined a wide variability of data within each irrigation method. Genotypes belonging to Indica subspecies are the best bioaccumulators of elements in both CF and SP methods and, never, the worst bioaccumulators for any element/irrigation method combination. In the principal component analysis, PC1 can differentiate samples irrigated by SP by those irrigated by CF and SA, whereas PC2 provides differentiation of CF samples by SA samples. When looking at the loading plot Ni is negatively correlated to the majority of the other elements, except Cu and Cd having negative loadings on PC2. These results allow to envisage that a proper combination of the irrigation method and the nature of rice genotype might be a very valuable tool in order to successfully achieve specific objectives of food safety or the attainment of functional properties
Prognostic model to predict postoperative acute kidney injury in patients undergoing major gastrointestinal surgery based on a national prospective observational cohort study.
Background: Acute illness, existing co-morbidities and surgical stress response can all contribute to postoperative acute kidney injury (AKI) in patients undergoing major gastrointestinal surgery. The aim of this study was prospectively to develop a pragmatic prognostic model to stratify patients according to risk of developing AKI after major gastrointestinal surgery. Methods: This prospective multicentre cohort study included consecutive adults undergoing elective or emergency gastrointestinal resection, liver resection or stoma reversal in 2-week blocks over a continuous 3-month period. The primary outcome was the rate of AKI within 7 days of surgery. Bootstrap stability was used to select clinically plausible risk factors into the model. Internal model validation was carried out by bootstrap validation. Results: A total of 4544 patients were included across 173 centres in the UK and Ireland. The overall rate of AKI was 14·2 per cent (646 of 4544) and the 30-day mortality rate was 1·8 per cent (84 of 4544). Stage 1 AKI was significantly associated with 30-day mortality (unadjusted odds ratio 7·61, 95 per cent c.i. 4·49 to 12·90; P < 0·001), with increasing odds of death with each AKI stage. Six variables were selected for inclusion in the prognostic model: age, sex, ASA grade, preoperative estimated glomerular filtration rate, planned open surgery and preoperative use of either an angiotensin-converting enzyme inhibitor or an angiotensin receptor blocker. Internal validation demonstrated good model discrimination (c-statistic 0·65). Discussion: Following major gastrointestinal surgery, AKI occurred in one in seven patients. This preoperative prognostic model identified patients at high risk of postoperative AKI. Validation in an independent data set is required to ensure generalizability
Sprinkler irrigation is effective in reducing cadmium concentration in rice (Oryza sativa L.) grain: A new twist on an old tale?
Polysaccharide Containing Gels for Pharmaceutical Applications
WOS: 000456875000007Bio-derived polymers are falling into the needs of pharmaceutical formulations for topical applications due to their gelling ability. Generally, in topical delivery, as an alternative way for local and systemic application of active substances, formulations in gelling form are preferred as they have multiple advantages, e.g., minimize systemic side effects, avoid gastrointestinal irritation, prevent the metabolism of the active substance in liver, etc. The present chapter reviews bio-based polymers with special reference to polysaccharides-based hydrogels with respect to their pharmaceutical applications
Remarkable body architecture of marine sponges as biomimetic structure for application in tissue engineering
Recent advances in the study of marine environment, particularly of marine organismsâ architecture and composition, have isolated interesting compounds as proteins, GAG-like polysaccharides and bioactive compounds. These compounds have allowed the development of panoply of biomaterials inspired by morphological characteristics and anatomical structures of the marine species. Besides, the scientific community acknowledges the enormous biotechnological potential in the marine resources that can be a promising effective and efficient alternative to be used in Human health, namely tissue engineering and regenerative medicine, as well as to support the progress in pharmacological, cosmetic, nutraceutical and biomedical fields. Additionally, sustainable ways are being applied to explore these marine resources and address biomimetic approaches, aiming to take the most out of the astonishing marine environment in ecologically compatible ways. Marine sponges are a particular group of organisms feeding these biotechnological developments for human health, both as source of new drugs or inspiration for the development of marine biomaterials. This chapter aims to demonstrate, in a concise and clear way, the biotechnological potential of marine sponges used as susceptive bioscaffolds for regenerative medicine and biomedical applications in general.Horizon 2020 European Union Framework Programme for Research and Innovation under project SponGES (H2020-BG-01-2015-679849) and from the European Research Council Advanced Grant ComplexiTE (grant agreement ERC-2012-ADG 20120216-321266